John M. Leonard, President and CEO at Intellia Therapeutics, Inc. (NTLA), sold 38,446 shares at $29.46 ($1.1M) on 2024-01-03, disclosed to the SEC on 2024-01-05.
Open-market sale of $1.1M NTLA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.46 | 19,223 | $566K | 50.0% |
| 2 | $29.46 | 19,223 | $566K | 50.0% |
| Total | $29.46 avg | 38,446 | $1.1M | 100% |
| Filing → |
| NTLA | SELL | 2025-12-12 | $1.7M | — | Filing → |
| NTLA | SELL | 2025-01-07 | $653K | — | Filing → |
| NTLA | SELL | 2023-01-06 | $497K | — | Filing → |